R0 Resection for Locally Advanced Pancreatic Cancer with Low-dose Gemcitabine with Wide Irradiation Area as Neoadjuvant Chemoradiotherapy

about

R0 Resection for Locally Advanced Pancreatic Cancer with Low-dose Gemcitabine with Wide Irradiation Area as Neoadjuvant Chemoradiotherapy

Item

http://www.wikidata.org/entity/Q58765908

description

wetenschappelijk artikel

@nl

wissenschaftlicher Artikel

@de

name

R0 Resection for Locally Advan ...... Neoadjuvant Chemoradiotherapy

@en

R0 Resection for Locally Advan ...... Neoadjuvant Chemoradiotherapy

@nl

type

Item

label

R0 Resection for Locally Advan ...... Neoadjuvant Chemoradiotherapy

@en

R0 Resection for Locally Advan ...... Neoadjuvant Chemoradiotherapy

@nl

prefLabel

R0 Resection for Locally Advan ...... Neoadjuvant Chemoradiotherapy

@en

R0 Resection for Locally Advan ...... Neoadjuvant Chemoradiotherapy

@nl

P1476

R0 Resection for Locally Advan ...... Neoadjuvant Chemoradiotherapy

@en

P2093

Akihisa Nagatsu

http://www.w3.org/2001/XMLSchema#string

Akinobu Taketomi

http://www.w3.org/2001/XMLSchema#string

Hideki Yokoo

http://www.w3.org/2001/XMLSchema#string

Hirofumi Kamachi

http://www.w3.org/2001/XMLSchema#string

Kenji Wakayama

http://www.w3.org/2001/XMLSchema#string

Norio Katoh

http://www.w3.org/2001/XMLSchema#string

Shingo Shimada

http://www.w3.org/2001/XMLSchema#string

Tatsuya Orimo

http://www.w3.org/2001/XMLSchema#string

Toshiya Kamiyama

http://www.w3.org/2001/XMLSchema#string

Yousuke Tsuruga

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer statistics, 2015

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey

Preoperative capecitabine and concurrent radiation for borderline resectable pancreatic cancer.

A multi-institutional phase 2 study of neoadjuvant gemcitabine and oxaliplatin with radiation therapy in patients with pancreatic cancer.

Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators.

Gemcitabine-based chemoradiotherapy followed by surgery for borderline resectable and locally unresectable pancreatic ductal adenocarcinoma: significance of the CA19-9 reduction rate and intratumoral human equilibrative nucleoside transporter 1 expr

Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial.

The Global Burden of Cancer 2013

Postoperative pancreatic fistula: an international study group (ISGPF) definition.

P304

1183-1191

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.21873/INVIVO.11362

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P698

30150442

http://www.w3.org/2001/XMLSchema#string

P921

Farmakologi

P932

6199618

http://www.w3.org/2001/XMLSchema#string